Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Mar 24, 2022 3:11pm
110 Views
Post# 34542647

RE:RE:RE:RE:RE:RE:RE:RE:Initial Take

RE:RE:RE:RE:RE:RE:RE:RE:Initial Take
MrMugsy wrote: Nice try Porky ....

I have one alias and I made it very clear when I changed my name - as one person was getting grossed out  by it.

I had no issue making the change for him.

Aside from that - I'm still huge on ATE ... not just for me but for GUD as well.  I believe the market has it all wrong ... we'll see.  I'm following all four platforms closely and I see markets valued at $131B.  But this is drug development - they need a first win for H2S technology to be taken seriously - very risky but Phase 2 data is amazing.  Sure the liver has issues past 20 days ... so don't focus on chronic, focus on acute until you solve the liver saturation issue. 

I bought Onconova as a flyer and I lost - no big deal - I said I was buying it as a flyer.

Synergy - I own at a few pennies per share - I'm losing money right now - let's see if I make/lose money as they go to the NASDAQ.

QPT - I paid 5 cents and I sold off the last spike from 25 cents (avg 15 cents) - nothing more than a flyer as well.

-------------------------

Man ... you are watching me like a hawk !!!!
Not sure watching me is going to help you.
You need to worry about yourself and don't let the markets get your blood boiling.
ATE doesn't have an Asprin version of their drug available yet.

: )





lol you waste so much time on obssessing over me. Any stock you touch turns to zero. That is an incredible skill.

Anyway, I'm done here. Booked a 10k loss and I'm gone. Gone from this vile turd of a company but not gone from this board. I will continue to warn this forum periodically of this inept management that has managed this into the ground. Now they slip into the call that they will likely be forced by governments in third worlds to lower their prices. Is this the JRG and Shakira recipe for growth? Good luck. I'll also warn people of the fraud that you are. So not really going anywhere,
<< Previous
Bullboard Posts
Next >>